PRESS RELEASE published on 09/11/2024 at 09:20, 1 year 11 months ago Eleving Group Announces its IPO plans and intention to list on the Nasdaq Riga Stock Exchange’s Baltic Main List and on the Frankfurt Stock Exchange’s regulated market (Prime Standard) Eleving Group announces IPO plans to list on Nasdaq Riga and Frankfurt Stock Exchange. Aims to expand business in vehicle and consumer financing across 16 markets and 3 continents Frankfurt Stock Exchange IPO Fintech Eleving Group Nasdaq Riga
PRESS RELEASE published on 09/11/2024 at 09:05, 1 year 11 months ago Q2 Metals Drills 347.1 Metre Interval of Continuous Spodumene-Pegmatite at its Cisco Lithium Property, James Bay Quebec Canada and Updates Financing Status Q2 Metals Corp. reports results from the Summer 2024 Drill Campaign, with significant spodumene-pegmatite intervals encountered in drill holes. Private placement financing completed for further exploration Exploration Private Placement Financing Q2 Metals Corp. Spodumene-pegmatite Intervals Summer 2024 Drill Campaign
PRESS RELEASE published on 09/11/2024 at 08:35, 1 year 11 months ago ENCAVIS acquires a ready-to-build wind farm in Dannhausen (18 MW) and further expands its wind portfolio in Germany to over 300 MW ENCAVIS acquires a ready-to-build 18 MW wind farm in Dannhausen, Germany, expanding its wind portfolio to over 300 MW. Construction by SOWITEC, connection in 2026 Acquisition Germany SOWITEC ENCAVIS Wind Farm
PRESS RELEASE published on 09/11/2024 at 08:32, 1 year 11 months ago Crédit Agricole Assurances announces the success of its previously launched Tender Offers, their Final Acceptance Amount and the Results Crédit Agricole Assurances announces the success of its Tender Offers, Final Acceptance Amount, and Results for 2014 and 2015 undated subordinated notes totaling €788.5 million Debt Management Subordinated Notes Tender Offers Crédit Agricole Assurances Final Acceptance Amount
PRESS RELEASE published on 09/11/2024 at 08:30, 1 year 11 months ago BiVictriX Therapeutics plc Shares now trading on JP Jenkins BiVictriX Therapeutics plc shares are now trading on JP Jenkins, providing a platform for shareholders to buy and sell equity. BiVictriX focuses on developing innovative cancer therapeutics JP Jenkins Shares Trading Shareholder Engagement Cancer Therapeutics BiVictriX Therapeutics Plc
PRESS RELEASE published on 09/11/2024 at 08:30, 1 year 11 months ago New World Closes Acquisition of Majority Stake in dialMKT Through Share Issuance New World Solutions Inc. completes Acquisition of 51% interest in dialMKT Corp, expanding into $31 billion wristwatch market with blockchain technology solutions Acquisition Blockchain Technology New World Solutions Inc. DialMKT Corp $31 Billion Wristwatch Market
PRESS RELEASE published on 09/11/2024 at 08:00, 1 year 11 months ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces transaction in own shares, purchasing 555,365 ordinary shares, cancelling them. Details of prices and volumes included. Share buyback program executed Share Buyback Program Cairn Homes Plc Euronext Dublin Own Shares Transaction
PRESS RELEASE published on 09/11/2024 at 08:00, 1 year 11 months ago EcoGraf Attends Leading Korean and Tanzanian EcoGraf Limited attends key industry events in Perth, discussing critical minerals, clean energy transitions, sustainable mineral development, and lithium-ion battery recycling Clean Energy Critical Minerals EcoGraf Limited Industry Events Lithium-ion Battery Recycling
REGULATED PRESS RELEASE published on 09/11/2024 at 08:00, 1 year 11 months ago EURAZEO AND KURMA PARTNERS INVEST IN THE EUR 93 MILLION FINANCING OF PANTERA TO ESTABLISH COMMERCIAL-SCALE PRODUCTION OF ACTINIUM-225 Eurazeo and Kurma Partners invest EUR 93 million in PanTera for Actinium-225 production to fight cancer, aiming to provide large-scale quantities by 2028 and cover 100,000 patients per year by 2029 EURAZEO Cancer Treatment Actinium-225 Kurma Partners European Healthcare
PRESS RELEASE published on 09/11/2024 at 07:45, 1 year 11 months ago Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
Published on 09/05/2026 at 04:05, 2 days 9 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 13 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 14 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 14 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 22 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/07/2026 at 12:45, 22 minutes ago VEVOR Brings Hands-on Product Demonstrations to IFA Berlin 2026
Published on 09/07/2026 at 12:37, 30 minutes ago Original-Research: PEH Wertpapier AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 09/07/2026 at 11:53, 1 hour 14 minutes ago paragon GmbH & Co. KGaA and two other companies of the paragon Group have filed for bankruptcy
Published on 09/07/2026 at 11:51, 1 hour 17 minutes ago EQS-Adhoc: paragon GmbH & Co. KGaA and two other companies in the paragon Group file for insolvency
Published on 09/04/2026 at 18:57, 2 days 18 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 17:45, 2 days 19 hours ago Declaration of voting rights at the end of August 2026
Published on 09/04/2026 at 16:00, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2026
Published on 09/04/2026 at 16:00, 2 days 21 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026